Update on the Development of Antagonists of Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2). From Lead Optimization to Clinical Proof-of-Concept in Asthma and Allergic Rhinitis
Author:
Affiliation:
1. Oxagen Ltd., 91 Milton Park, Abingdon, Oxon OX14 4RY, U.K.
2. Evotec (U.K.) Ltd 114 Milton Park Abingdon Oxon OX14 4SA, U.K.
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm2013997
Reference118 articles.
1. Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2
2. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases
3. Novel CRTH2 antagonists: a review of patents from 2006 to 2009
4. DP2receptor antagonists in development
5. Prostaglandin D2 Receptor CRTH2 Antagonists for the Treatment of Inflammatory Diseases
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Electrochemical selective divergent C–H chalcogenocyanation of N-heterocyclic scaffolds;Organic & Biomolecular Chemistry;2024
2. Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma;Journal of Genetic Engineering and Biotechnology;2023-12
3. Indole-Based and Cyclopentenylindole-Based Analogues Containing Fluorine Group as Potential 18F-Labeled Positron Emission Tomography (PET) G-Protein Coupled Receptor 44 (GPR44) Tracers;Pharmaceuticals;2023-08-24
4. Electrochemical direct C–H mono and bis-chalcogenation of indolizine frameworks under oxidant-free conditions;Organic & Biomolecular Chemistry;2023
5. The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant;Pulmonary Pharmacology & Therapeutics;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3